Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.

The Journal of biological chemistry - 4 Aug 2000

Aviel S, Winberg G, Massucci M, Ciechanover A

Abstract excerpt

The latent membrane protein 1 (LMP1) of the Epstein-Barr virus is a constitutively active receptor essential for B lymphocyte transformation by the Epstein-Barr virus. It is a short-lived protein, but the proteolytic pathway involved in its degradation is not known. The ubiquitin pathway is a major system for specific protein degradation in eukaryotes. Most plasma membrane substrates of the pathway are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Compartmentation
Share to Cell-Free System

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cysteine Endopeptidases

Share to Half-Life

Share to Lymphoproliferative Disorders

Share to Oncogene Proteins, Viral

Share to Ubiquitins

Share to Viral Matrix Proteins

Source

Identifiers

PMID: 10807912
DOI: 10.1074/jbc.M002052200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.PMID 10807912Read ↗

Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitinationSemantic proximity Read ↗

A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.Semantic proximity Read ↗

Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor SignalingSemantic proximity Read ↗

Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase.Semantic proximity Read ↗

The Latent Membrane Protein 1 (LMP1) Oncogene of Epstein-Barr Virus Can Simultaneously Induce and Inhibit Apoptosis in B CellsSemantic proximity Read ↗

Epstein-Barr Virus Deubiquitinase Downregulates TRAF6-Mediated NF-κB Signaling during Productive ReplicationSemantic proximity Read ↗

Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.Semantic proximity Read ↗

Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity.Semantic proximity Read ↗

Regulation of HPV-16 infection by ubiquitination of the L1 major capsid protein.Semantic proximity Read ↗

The Epstein-Barr virus deubiquitinase BPLF1 targets SQSTM1/p62 to inhibit selective autophagy.Semantic proximity Read ↗

Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3Semantic proximity Read ↗

Functionally significant mutations in the Epstein-Barr virus LMP1 gene and their role in activation of cell signaling pathways.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.